"VILDIABATE PIO: Diabetes Control Combo"

Jun 01, 2024

VILDIABATE PIO 

Vildagliptin 50 mg & Pioglitazone Hydrochloride 15 mg

Introduction

VILDIABATE PIO is a combination medication that includes Vildagliptin 50 mg and Pioglitazone Hydrochloride 15 mg. This article explores the uses, benefits, dosage, potential side effects, and precautions associated with this powerful combination in managing type 2 diabetes mellitus.

Understanding VILDIABATE PIO

  • Dual Action: Vildagliptin and Pioglitazone work synergistically to improve glycemic control in individuals with type 2 diabetes by targeting different aspects of glucose metabolism.
  • Vildagliptin (50 mg): It is a dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances insulin secretion and reduces glucagon levels, thereby lowering blood glucose levels.
  • Pioglitazone Hydrochloride (15 mg): This medication belongs to the thiazolidinedione class and improves insulin sensitivity in peripheral tissues, helping to lower insulin resistance.

Benefits of VILDIABATE PIO

  • Blood Sugar Regulation: The combination of Vildagliptin and Pioglitazone helps maintain stable blood sugar levels throughout the day, reducing the risk of hyperglycemia.
  • Improved Insulin Sensitivity: Pioglitazone's action on insulin sensitivity complements Vildagliptin's effects on insulin secretion, providing a comprehensive approach to diabetes management.
  • Cardiovascular Benefits: Some studies suggest that Pioglitazone may have additional cardiovascular benefits beyond glycemic control.

Dosage and Administration

  • Recommended Dosage: The standard dosage of VILDIABATE PIO is one tablet taken once daily, preferably with meals to minimize gastrointestinal side effects.
  • Individualized Treatment: Dosage adjustments may be necessary based on individual patient response, kidney function, and other medical factors. Follow your healthcare provider's instructions regarding dosage adjustments.
  • Administration: Take the tablet orally with a full glass of water. Consistency in medication schedule is crucial for optimal results.

Side Effects and Precautions

  • Common Side Effects: Patients may experience mild side effects such as nausea, diarrhea, headache, or weight gain. These side effects typically resolve with continued use.
  • Serious Side Effects: Rare but serious side effects include hypoglycemia, fluid retention, or liver function abnormalities. Promptly report any unusual symptoms to your healthcare provider.
  • Precautions: Inform your doctor about any pre-existing medical conditions, allergies, or medications you are taking to avoid potential drug interactions or adverse effects.

Conclusion

VILDIABATE PIO, combining Vildagliptin 50 mg and Pioglitazone Hydrochloride 15 mg, is an effective treatment option for type 2 diabetes mellitus. Adhering to the prescribed dosage, monitoring for side effects, and making necessary lifestyle modifications can help optimize the benefits of this medication. Consult your healthcare provider for personalized medical advice and diabetes management strategies.Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

  For further information: 

 

 EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

 

   BUY NOW


 

 

 

SHARE WITH